Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
David M. Routman, M.D.'s research aims to personalize radiation oncology treatment across multiple malignancies by translating science and technology into clinical application. He is co-founder of Mayo Clinic's Radiation Oncology Informatics Laboratory with a specialized focus on using advances in data science and technology to improve the quality of care while minimizing toxicity. Dr. Routman focuses on patient-reported outcomes, wearable technologies, novel biomarkers, and radiation therapy advances including proton therapy and automation.
By translating biomarkers and automated and predictive tools into clinical practice, Dr. Routman's goal is to design workflows that provide the highest quality, least intensive and individually most appropriate treatment to each person.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.